Antioxidants & Redox Signaling (ARS) is the leading peer-reviewed journal dedicated to understanding the vital impact of oxygen and oxidation-reduction (redox) processes on human health and disease. The Journal explores key issues in genetic, pharmaceutical, and nutritional redox-based therapeutics. Cutting-edge research focuses on structural biology, stem cells, regenerative medicine, epigenetics, imaging, clinical outcomes, and preventive and therapeutic nutrition, among other areas.
ARS has expanded to create two unique foci within one journal: ARS Discoveries and ARS Therapeutics. ARS Discoveries (24 issues) publishes the highest-caliber breakthroughs in basic and applied research. ARS Therapeutics (12 issues) is the first publication of its kind that will help enhance the entire field of redox biology by showcasing the potential of redox sciences to change health outcomes.
ARS coverage includes:
-ROS/RNS as messengers
-Gaseous signal transducers
-Hypoxia and tissue oxygenation
-microRNA
-Prokaryotic systems
-Lessons from plant biology
《Antioxidants & Redox Signaling》是一本由MARY ANN LIEBERT, INC出版商出版的专业生物期刊,该刊创刊于1999年,刊期Semimonthly,该刊已被国际权威数据库SCIE、SCI收录。在中科院最新升级版分区表中,该刊分区信息为大类学科:生物学 2区,小类学科:生化与分子生物学 2区;内分泌学与代谢 2区;在JCR(Journal Citation Reports)分区等级为Q1。该刊发文范围涵盖生化与分子生物学等领域,旨在及时、准确、全面地报道国内外生化与分子生物学工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等,促进学术交流,鼓励学术创新。2021年影响因子为7.468,平均审稿速度一般,3-6周。
大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
生物学 | 2区 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 ENDOCRINOLOGY & METABOLISM 内分泌学与代谢 | 2区 2区 | 否 | 否 |
JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
Q1 | BIOCHEMISTRY & MOLECULAR BIOLOGY | Q1 | 7.468 |
ENDOCRINOLOGY & METABOLISM | Q1 |
影响因子 | h-index | Gold OA文章占比 | 研究类文章占比 | OA开放访问 | 平均审稿速度 |
7.468 | 162 | 9.40% | 90.76% | 未开放 | 一般,3-6周 |